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Introduction
Despite attempts to establish a situation of tolerance
to an allograft, at present, kidney transplantation is
inevitably associated with the use of immunosuppres-
sive drugs and, consequently, an increased risk of
infection [1,2]. Here we present a patient with a kidney
transplant who developed a bacteraemia with Yersinia
pseudotuberculosis 5 years after transplantation, which
is a rare complication of Y.pseudotuberculosis infection
and has been reported only once before in the context
of kidney transplantation.
Case
A 54-year-old man was admitted in 1999 because of
fever (up to 39.78C) and chills, which were present for
1 week. Three days prior to admission, erythromycin
was added to his medication. Five years earlier,
peritoneal dialysis was initiated because of renal failure
due to focal segmental glomerulosclerosis, and a few
months later he received a cadaveric kidney transplant.
His immunosuppressive treatment consisted of cyclo-
sporine and low dose prednisone (10 mg once daily)
for 1 year; thereafter cyclosporine was converted to
mycophenolate mofetil (MMF). For the next 3 years
his immunosuppressive medication was unchanged
while his kidney function was stable with a serum
creatinine level of 235 mmolul. On admission, apart
from a systolic murmur (2u6), physical examination did
not show any abnormalities.
On laboratory examination, haemoglobin was
6.4 mmolul, platelet count 2533109ul and leukocyte
count 5.63109ul. Serum urea was 17.2 mmolul and
creatinine 263 mmolul. C-reactive protein level (CRP)
was elevated (110 mgul) and ESR was 37 mmuh. Blood
glucose level was normal (5.9 mmolul), serum iron
5 mmolul, transferrin 1.9 gul and ferritin 664 mmolul.
An X-ray of the chest showed no signs of infection.
An ultrasonography of the abdomen showed a normal
kidney transplant and a normal liver, while the spleen
was 11 cm and contained multiple small hypo-
echogenic lesions, -1 cm in diameter, suggestive of
abscesses. A CAT scan of the abdomen confirmed
multiple small hypodense lesions in the spleen, sugges-
tive of the presence of abscesses, cysts or lymphomas
(Figure 1). Sterile blood cultures, taken repeatedly on
consecutive days, in combination with a normal
transoesophagal echocardiography ruled out an
endocarditis. All cultures of faeces, urine, sputum
and bone marrow remained sterile, and no evidence
of viral infection was found. An ultrasound-guided
sample taken from a lesion in the spleen did not
reveal malignancy or granulomas, but showed many
Fig. 1. CAT scan of the abdomen, showing multiple small lesions in
the spleen.
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segmented neutrophils, indicating an abscess. Cultures
of this specimen for bacteria, mycobacteria and fungi
remained sterile.
After a few episodes of spiking fever, with a
maximum of 39.58C, temperature normalized and
CRP decreased. No antibiotic treatment was prescribed
and immunosuppressive therapy was not reduced. A
month later, a CAT scan of the abdomen showed a
normal spleen, without focal lesions (Figure 2). The
patient was discharged from the hospital, but
remained under observation at the outpatients’ clinic.
Two months later he was readmitted, presenting
with severe lower back pain, chills and fever up to
398C. He also complained of vomiting and diarrhea
and had recently gone through a period of coughing.
Physical examination again revealed no abnormalities,
his temperature was 37.28C and laboratory exami-
nation was similar to the previous admission. A third
CAT scan of the abdomen again showed lesions in the
spleen, which were smaller than at the previous
admission. In addition, multiple small lesions in both
lungs were seen on both an X-ray and a CAT scan of
the chest. On a bone scintigraphy, no abnormalities
were found; however, magnetic resonance imaging
(MRI) of the lumbar spine, performed because of
persisting lower back pain, showed an osteolytic lesion
in the first lumbar vertebral body, strongly suggestive
of malignancy. Because of spiking fever up to 39.58C
and suspicion of a disseminated bacterial infection,
treatment with cefuroxime was started. Four blood
cultures yielded Y.pseudotuberculosis. The minimal
inhibitory concentration (MIC) of cefuroxime against
the Yersinia strain was 0.25 mgul, while the MIC of
erythromycin, doxycycline, gentamicin and cipro-
floxacin were 8, 0.50, 0.50 and 0.032 mgul, respectively.
Consequently, antibiotic treatment was changed to
ciprofloxacin 500 mg b.d., orally.
During the next 2 weeks, the fever disappeared,
CRP decreased (24 mgul) and the lesions in the lung
almost completely disappeared. However, on a second
MRI of the lumbar spine, an increase of the osteolytic
lesion was seen, complicated by a fracture of the upper
substantia compacta. In order to rule out malignancy,
a bone biopsy was taken that showed fibrosis and signs
of inflammation. No malignant cells were found and
cultures of the biopsy specimen (including culture for
mycobacteria) remained sterile. Because of the severity
of the infection it was decided to continue the cipro-
floxacin treatment for a prolonged period. The patient
was discharged from the hospital and the antibiotic
treatment was continued for 4 months.
Two months after discharge, the osteolytic lesion in
L1 remained stable and showed signs of sclerosis.
Now, 2 years later, the patient is still well.
Discussion
Infection with Y.pseudotuberculosis is uncommon in
humans. It is a zoonotic infection with reservoirs in
rodents, birds and mammals. Transmission to humans
occurs through ingestion of contaminated food or
direct contact with an infected animal. Our patient,
being a former pigeon fancier, reported to be still in
contact with pigeons weekly. He may possibly have
contracted Yersinia through his hobby. The infection
commonly manifests as mesenteric lymphadenitis with
fever, abdominal pain, and less often vomiting and
diarrhea. This syndrome is most common in children
and adolescents, and may be indistinguishable from
acute appendicitis. Erythema nodosum and poly-
arthritis have also been described [3]. The bacteremic
form of Y.pseudotuberculosis infection is rare. Until
now 59 cases have been reported [4,5]. As a complica-
tion of bacteraemia, abscesses may occur in various
organ systems (e.g. lungs, liver, meninges). In many
cases bacteraemia is connected with an underlying
disorder such as liver cirrhosis, haemochromatosis,
hepatitis or diabetes [4–6]. Iron overload, which is
known to be a predisposing factor in Yersinia
enterocolitica infection, also seems to play a role in
the development of Y.pseudotuberculosis bacteraemia
considering the association with liver cirrhosis and
haemochromatosis [7]. Iron overload, liver disease and
diabetes were excluded in our patient.
To the best of our knowledge, only one patient with
a kidney transplant has been reported to develop
Y.pseudotuberculosis bacteraemia [4,8]. Apart from the
immunosuppressive treatment, which had not been
changed recently, no predisposing factors could be
defined in our patient. In fact the overall amount of
immunosuppressive treatment was on the low side in
this patient. Prior to the development of this infection
his cyclosporine treatment was changed into MMF.
In the literature, the use of MMF has not been
reported to be associated with an increased incidence
of opportunistic infections as compared with other
immunosuppressant drugs. As initially no causative
microorganisms were found and the patient recovered
Fig. 2. CAT scan of the abdomen from the same patient, 1 month
later. No more lesions are visible in the spleen.
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soon, no antibiotic treatment was prescribed. In retro-
spect, this spontaneous recovery seems to be remark-
able. Considering the high MIC of erythromycin, it
seems unlikely that the short antibiotic course before
admission was effective. There is circumstantial
evidence to suggest that the osteolytic lesion in L1
may have also been due to the Y.pseudotuberculosis
infection, although osteomyelitis due to Y.pseudo-
tuberculosis has not been described before. At the
second admission our patient reported episodes of
fever for at least 4 weeks, which suggest he went
through a prolonged period of bacteraemia. Although
it has never been described before inY.pseudotuberculosis
infection, it seems probable that the prolonged
bacteraemia in our patient led to osteomyelitis, as
can occur in other bacterial infections. It is true
that cultures of the biopsy material remained sterile;
however, the biopsy was taken 1 month after the
ciprofloxacin treatment was started. In the bone
lesion, no evidence was found for other causative
microorganisms or malignancy while during follow-
up, no signs of metastatic (bone) disease became
manifest.
Yersinisa pseudotuberculosis is usually sensitive to
ampicillin, tetracycline, chloramphenicol, cephalo-
sporins, fluoroquinolones and aminoglycosides [9].
Although Y.pseudotuberculosis is susceptible to cepha-
losporines in vitro, experimental studies have shown
that fluoroquinolones, gentamicin and doxycycline
result in better killing in vivo [10]. In our patient,
however, gentamicin was not an option because of the
impaired renal function, and doxycycline, being a
bacteriostatic drug, was considered a poor choice in
this patient under immunosuppressive treatment.
Despite antibiotic treatment, deaths still occur from
septicaemia with Y.pseudotuberculosis. A mortality
rate of 75% was reported despite antibiotic treatment
[3]; however, in a review of 1995 mortality rate was
considerably lower (18%) [4].
In this report we describe a kidney transplant
patient who developed the bacteremic form of
Y.pseudotuberculosis infection, which has been
reported previously only once in a transplant recipient.
In addition, there is circumstantial evidence that in this
case Y.pseudotuberculosis bacteraemia was possibly
complicated by osteomyelitis, a complication never
described before.
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